A congressional committee has approved a large-scale defense bill that includes GOP-led provisions to create a medical marijuana “pilot program” and require a study into the therapeutic potential of psychedelics for active duty military members under the U.S. Department of Defense (DOD).
The House Armed Services Committee held a markup of the National Defense Authorization Act (NDAA) on Wednesday, approving the legislation with drug policy reform amendments from Reps. Nancy Mace (R-SC) and Morgan Luttrell (R-TX), which were both adopted in a voice vote as par of an en bloc package.
Mace’s amendment calls for a DOD medical cannabis pilot program that would examine the health impacts of marijuana use by veterans and service members who are U.S. Department of Veterans Affairs (VA) beneficiaries. To be eligible for the program, the VA participant would need to have been diagnosed with post-traumatic stress disorder (PTSD), depression or anxiety, or have been prescribed pain management.
The secretaries of defense and VA would need to assess, compile and publish “relevant data collected by State-approved marijuana regulatory programs and made available to the Secretary of Defense.”
🍃🔥 BIG DEAL 🔥🍃
Our amendment 3504 – a medical #marijuana pilot program just PASSED @HASCRepublicans! @SecDef
Read full article on Marijuana Moment
